亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

        2021-01-07 23:21:09EdwardWalshetal
        四川生理科學(xué)雜志 2021年1期

        Edward E Walsh, et al.

        Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the resulting disease,coronavirus disease 2019 (Covid-19), have spread to millions of persons worldwide.Multiple vaccine candidates are under development, but no vaccine is currently available.Interim safety and immunogenicity data about the vaccine candidate BNT162b1 in younger adults have been reported previously from trials in Germany and the United States.

        Methods: In an ongoing, placebo-controlled, observer-blinded, dose-escalation, phase 1 trial conducted in the United States,we randomly assigned healthy adults 18 to 55 years of age and those 65 to 85 years of age to receive either placebo or one of two lipid nanoparticle-formulated, nucleoside-modified RNA vaccine candidates: BNT162b1, which encodes a secreted trimerized SARS-CoV-2 receptor-binding domain; or BNT162b2, which encodes a membrane-anchored SARS-CoV-2 full-length spike, stabilized in the prefusion conformation.The primary outcome was safety (e.g., local and systemic reactions and adverse events); immunogenicity was a secondary outcome.Trial groups were defined according to vaccine candidate, age of the participants, and vaccine dose level (10 μg, 20 μg, 30 μg, and 100 μg).In all groups but one, participants received two doses, with a 21-day interval between doses; in one group (100 μg of BNT162b1), participants received one dose.

        Results: A total of 195 participants underwent randomization.In each of 13 groups of 15 participants, 12 participants received vaccine and 3 received placebo.BNT162b2 was associated with a lower incidence and severity of systemic reactions than BNT162b1, particularly in older adults.In both younger and older adults, the two vaccine candidates elicited similar dose-dependent SARS-CoV-2-neutralizing geometric mean titers, which were similar to or higher than the geometric mean titer of a panel of SARS-CoV-2 convalescent serum samples.

        Conclusions: The safety and immunogenicity data from this U.S.phase 1 trial of two vaccine candidates in younger and older adults, added to earlier interim safety and immunogenicity data regarding BNT162b1 in younger adults from trials in Germany and the United States, support the selection of BNT162b2 for advancement to a pivotal phase 2-3 safety and efficacy evaluation.(Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04368728.).

        影音先锋色小姐| 91精品国产综合久久国产| 国产男女乱婬真视频免费| 亚洲一区二区三区综合网| 久久精品国产av麻豆五月丁| 国产边摸边吃奶叫床视频| 99久久精品费精品国产一区二区| 亚洲中文字幕在线一区二区三区| 成年男人午夜视频在线看| 久久久亚洲免费视频网| 久久精品国产亚洲av香蕉| 丝袜足控一区二区三区| 国产精品爽爽va在线观看网站| 亚洲麻豆av一区二区| 人妻少妇偷人精品久久性色av| 亚洲国产日韩欧美一区二区三区| 久久久AV无码精品免费| 91亚洲精品久久久中文字幕| 国产精品婷婷久久爽一下| 国产精品久久毛片av大全日韩| 亚洲天天综合色制服丝袜在线| 久久精品国产亚洲av日韩一| 蜜桃视频插满18在线观看| 亚洲乱码中文字幕综合| 亚洲AV无码永久在线观看| 人妻少妇中文字幕久久hd高清| 极品嫩模大尺度av在线播放| 久久久久久久岛国免费观看| 午夜影视啪啪免费体验区入口 | 一区二区三区四区黄色av网站| 久久精品国产成人午夜福利| 熟妇高潮一区二区三区| 成人区视频| 亚洲人妻av在线播放| 国产精品视频永久免费播放| 亚洲依依成人亚洲社区| 久九九久视频精品网站| 美女丝袜美腿玉足视频| 中文字幕无码日韩专区免费| 天天射色综合| 久久影院最新国产精品|